Boyer, Julie L.

Publications

Sort by

Co-Author Network

selected publications

The Use of Intraoperative Peripheral Extracorporeal Membrane Oxygenation in High-Risk Airways Tumor Removal Procedures in Neonates and Children: A Single-Center Case Series. 2021 GET IT
Times cited: 2
A Novel Small-Molecule Inhibitor Targeting CREB-CBP Complex Possesses Anti-Cancer Effects along with Cell Cycle Regulation, Autophagy Suppression and Endoplasmic Reticulum Stress. PloS one. 2015 Academic Article GET IT
Times cited: 19
Bis(imino)pyridine cobalt-catalyzed dehydrogenative silylation of alkenes: scope, mechanism, and origins of selective allylsilane formation. Journal of the American Chemical Society. 2014 Academic Article GET IT
Times cited: 168
A RAS renaissance: emerging targeted therapies for KRAS-mutated non-small cell lung cancer. Clinical cancer research : an official journal of the American Association for Cancer Research. 2014 Review GET IT
Times cited: 74
"Quitting smoking will benefit your health": the evolution of clinician messaging to encourage tobacco cessation. Clinical cancer research : an official journal of the American Association for Cancer Research. 2014 Review GET IT
Times cited: 53
A step towards treating KRAS-mutant NSCLC. The Lancet. Oncology. 2012 Comment GET IT
Times cited: 7
Targeting vascular endothelial growth factor in patients with squamous cell lung cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2012 Academic Article GET IT
Times cited: 6
Effects of a proximal base on water oxidation and proton reduction catalyzed by geometric isomers of [Ru(tpy)(pynap)(OH2)]2+. Angewandte Chemie (International ed. in English). 2011 Academic Article GET IT
Times cited: 89
Persistent suppression of ocular neovascularization with intravitreal administration of AAVrh.10 coding for bevacizumab. Human gene therapy. 2011 Academic Article GET IT
Times cited: 20
AAVrh.10-mediated genetic delivery of bevacizumab to the pleura to provide local anti-VEGF to suppress growth of metastatic lung tumors. Gene therapy. 2010 Academic Article GET IT
Times cited: 39
Protective immunity against a lethal respiratory Yersinia pestis challenge induced by V antigen or the F1 capsular antigen incorporated into adenovirus capsid. Human gene therapy. 2010 Academic Article GET IT
Times cited: 30
Persistent expression of biologically active anti-HER2 antibody by AAVrh.10-mediated gene transfer. Cancer gene therapy. 2010 Academic Article GET IT
Times cited: 22
Affinity maturation of an anti-V antigen IgG expressed in situ through adenovirus gene delivery confers enhanced protection against Yersinia pestis challenge. Gene therapy. 2010 Academic Article GET IT
Times cited: 19
Oxidation state characterization of ruthenium 2-iminoquinone complexes through experimental and theoretical studies. Inorganic chemistry. 2010 Academic Article GET IT
Times cited: 20
Genetic delivery of bevacizumab to suppress vascular endothelial growth factor-induced high-permeability pulmonary edema. Human gene therapy. 2009 Academic Article GET IT
Times cited: 23
Functional cystic fibrosis transmembrane conductance regulator expression in cystic fibrosis airway epithelial cells by AAV6.2-mediated segmental trans-splicing. Human gene therapy. 2009 Academic Article GET IT
Times cited: 48
Redox activation of alkene ligands in platinum complexes with non-innocent ligands. Inorganic chemistry. 2009 Academic Article GET IT
Times cited: 34
Adenovirus-mediated delivery of an anti-V antigen monoclonal antibody protects mice against a lethal Yersinia pestis challenge. Infection and immunity. 2009 Academic Article GET IT
Times cited: 30
Generation of a functional and durable vascular niche by the adenoviral E4ORF1 gene. Proceedings of the National Academy of Sciences of the United States of America. 2008 Academic Article GET IT
Times cited: 110
Genetic delivery of an anti-RSV antibody to protect against pulmonary infection with RSV. Virology. 2008 Academic Article GET IT
Times cited: 45
Genetic delivery of the murine equivalent of bevacizumab (avastin), an anti-vascular endothelial growth factor monoclonal antibody, to suppress growth of human tumors in immunodeficient mice. Human gene therapy. 2008 Academic Article GET IT
Times cited: 13
Rapid/sustained anti-anthrax passive immunity mediated by co-administration of Ad/AAV. Molecular therapy : the journal of the American Society of Gene Therapy. 2007 Academic Article GET IT
Times cited: 37
Evolution of organo-cyanometallate cages: supramolecular architectures and new Cs+-specific receptors. Accounts of chemical research. 2007 Academic Article GET IT
Redox-switched complexation/decomplexation of K(+) and Cs(+) by molecular cyanometalate boxes. Journal of the American Chemical Society. 2007 Academic Article GET IT
Isolation, growth, and purification of defective adenovirus deletion mutants. Methods in molecular medicine. 2007 Academic Article GET IT
Times cited: 2
Manipulation of early region 4. Methods in molecular medicine. 2007 Review GET IT
Times cited: 1
Protective immunity against respiratory tract challenge with Yersinia pestis in mice immunized with an adenovirus-based vaccine vector expressing V antigen. The Journal of infectious diseases. 2006 Academic Article GET IT
Times cited: 42
Genetic medicine strategies to protect against bioterrorism. Transactions of the American Clinical and Climatological Association. 2006 Review GET IT
Times cited: 4
Induction of protective immunity to anthrax lethal toxin with a nonhuman primate adenovirus-based vaccine in the presence of preexisting anti-human adenovirus immunity. Infection and immunity. 2005 Academic Article GET IT
Times cited: 52
Identification of murine CD8 T cell epitopes in codon-optimized SARS-associated coronavirus spike protein. Virology. 2005 Academic Article GET IT
Times cited: 59
Adenovirus-based genetic vaccines for biodefense. Human gene therapy. 2005 Review GET IT
Times cited: 42
Passive immunotherapy for anthrax toxin mediated by an adenovirus expressing an anti-protective antigen single-chain antibody. Molecular therapy : the journal of the American Society of Gene Therapy. 2005 Academic Article GET IT
Times cited: 26
Resolution of primary severe acute respiratory syndrome-associated coronavirus infection requires Stat1. Journal of virology. 2004 Academic Article GET IT
Times cited: 111
Protective immunity evoked against anthrax lethal toxin after a single intramuscular administration of an adenovirus-based vaccine encoding humanized protective antigen. Human gene therapy. 2003 Academic Article GET IT
Times cited: 58
The Epstein-Barr virus SM protein is functionally similar to ICP27 from herpes simplex virus in viral infections. Journal of virology. 2002 Academic Article GET IT
Times cited: 25
Genetic analysis of a potential zinc-binding domain of the adenovirus E4 34k protein. The Journal of biological chemistry. 2000 Academic Article GET IT
Times cited: 33
Adenovirus E4 34k and E4 11k inhibit double strand break repair and are physically associated with the cellular DNA-dependent protein kinase. Virology. 1999 Academic Article GET IT
Times cited: 123
Fish stories: 100 years at Mount Desert Island Biological Laboratory. Transactions of the American Clinical and Climatological Association. 1998 Academic Article GET IT
Times cited: 1

more ...

less ...

Research

Sort by

Co-investigator Network

Funding awarded

CAP-IT Center for LNP RNA Immunoprevention awarded by National Cancer Institute Key Personnel 2022 - 2027
Weill Cornell Medicine (WCM) SPORE in Prostate Cancer awarded by National Cancer Institute Key Personnel 2017 - 2023

more ...

less ...

Background

education and training

Ph.D., The Johns Hopkins University School of Hygiene and Public Health 1999
B.S., University of Pittsburgh 1991

Contact

full name

Julie L. Boyer

primary email

Julie.boyer@med.cornell.edu

VIVO Weill Cornell Medical College

Julie L. Boyer Associate Dean for Research

Publications

selected publications

Research

Funding awarded

Background

education and training

Contact

full name

primary email

Phone

Publications

selected publications

Research

Funding awarded

Background

education and training

Contact

full name

primary email